Related Experiment Video
Updated: Jun 4, 2026
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
Published on: November 7, 2015
Culture of human normal brain and malignant brain tumors for cellular, molecular, and pharmacological studies
1Department of Experimental Pediatrics Section of Molecular Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX.
Abstract:
Human brain neoplasms comprise a highly heterogeneous and biologically diverse group of tumors, the most common and most malignant of which are those of neuroepithelial origin (1) Despite intensive research, little is still understood about the cellular and molecular processes involved in the genesis, progression, and response to therapy of these tumors. Much of the progress made to date, however, has resulted, in part from advances in the ability to culture and propagate cells of both normal and neoplastic brain tissue in vitro (2, 3) For example, in vitro cultures have contributed significantly to the development of techniques, such as bromodeoxyuridine labeling, that are used to estimate the cell-growth kinetics of gliomas in patients (4) Normal brain and brain tumor cultures have also played a central role in research directed at a better understanding of the complex interplay between the cellular components of the brain, such as that between various glial cells, neurons, and endothelial cells (5, 6) In studies of the molecular and cellular mechanisms involved in brain tumor resistance to therapy, in vitro cultures of human glioma cells have played a significant role in the identification of O(6)-alkylguanine DNA alkyltransferase (7), glutathione, and glutathione S-transferases (8), as critical factors in human brain tumor alkylator resistance, findings that are providing the basis for novel therapies for human gliomas. Neurobiology and neurooncology research will therefore continue to be critically dependent on appropriate in vitro models of normal and neoplastic brain cells.
Insights
In vitro cultures of human brain cells are crucial for understanding brain tumor development and therapy resistance. These models help identify key factors in glioma alkylator resistance, paving the way for new treatments.
Area of Science:
- Neurobiology
- Neuro-oncology
- Cancer Research
Background:
- Human brain neoplasms are diverse, with neuroepithelial tumors being the most common and malignant.
- Understanding the cellular and molecular basis of brain tumor genesis, progression, and therapy response remains a challenge.
- Advances in in vitro cell culture techniques have been pivotal in neuro-oncology research.
Purpose of the Study:
- To highlight the critical role of in vitro models in advancing the understanding of human brain neoplasms.
- To emphasize the contribution of cell cultures to studying glioma cell-growth kinetics and cellular interactions.
- To underscore the importance of in vitro models in identifying mechanisms of brain tumor therapy resistance.
Main Methods:
- Utilizing in vitro cultures of normal and neoplastic human brain cells.
- Employing techniques like bromodeoxyuridine labeling for cell-growth kinetics analysis.
- Investigating molecular and cellular mechanisms of therapy resistance in human glioma cells.
Main Results:
- In vitro cultures have facilitated the development of techniques for estimating glioma cell-growth kinetics.
- Cell cultures have aided in understanding the interplay between glial cells, neurons, and endothelial cells.
- Studies using glioma cell cultures identified O(6)-alkylguanine DNA alkyltransferase and glutathione S-transferases as critical factors in alkylator resistance.
Conclusions:
- In vitro models of normal and neoplastic brain cells are indispensable for neurobiology and neuro-oncology research.
- Findings from in vitro studies are forming the basis for novel therapeutic strategies for human gliomas.
- Continued reliance on appropriate in vitro models is essential for future progress in brain tumor research.
